logo
logo

Glen Clova Scientific raises £4M in a Seed round led by Norcliffe Capital to develop drugs for autoimmune diseases

Glen Clova Scientific raises £4M in a Seed round led by Norcliffe Capital to develop drugs for autoimmune diseases

04/25/24, 12:10 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/GB.svgdundee
Money raised
£4 million
Industry
biotechnology
Round Type
seed
Investors
Scottish Enterprise, Tricapital Angels, Dsw Ventures, Norcliffe Capital
Glen Clova Scientific has closed a £4M Seed round, led by Norcliffe Capital. The funding will be used to advance preclinical development of three initial drugs for the treatment of senile pruritus, atopic dermatitis, eczema, and asthma, as well as to exploit its technology platform in non-pharmaceutical markets through partnerships.

Company Info

Company
Glen Clova Scientific
Location
dundee, scotland, united kingdom
Additional Info
Scottish biotech startup Glen Clova Scientific is developing drugs for chronic inflammatory and autoimmune disorders. It was founded in 2022 as a spin out from the University of Dundee.

Related People